Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 512

1.

Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance.

Powis Z, Farwell Hagman KD, Mroske C, McWalter K, Cohen JS, Colombo R, Serretti A, Fatemi A, David KL, Reynolds J, Immken LD, Nagakura H, Cunniff C, Payne K, Barbaro-Dieber T, Gripp KW, Baker L, Stamper T, Aleck KA, Jordan ES, Hersh J, Burton J, Wentzensen IM, Guillen Sacoto MJ, Willaert R, Cho MT, Petrik I, Huether R, Tang S.

Clin Genet. 2017 Sep 7. doi: 10.1111/cge.13132. [Epub ahead of print]

PMID:
28881385
2.

Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder.

Fabbri C, Serretti A.

Am J Med Genet B Neuropsychiatr Genet. 2017 Oct;174(7):757-764. doi: 10.1002/ajmg.b.32577. Epub 2017 Aug 8.

PMID:
28786528
3.

Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trials.

Corponi F, Serretti A, Montgomery S, Fabbri C.

Int Clin Psychopharmacol. 2017 Nov;32(6):309-318. doi: 10.1097/YIC.0000000000000189.

PMID:
28727644
4.

Escitalopram plasma levels and antidepressant response.

Florio V, Porcelli S, Saria A, Serretti A, Conca A.

Eur Neuropsychopharmacol. 2017 Sep;27(9):940-944. doi: 10.1016/j.euroneuro.2017.06.009. Epub 2017 Jun 23.

PMID:
28648553
5.

Genetics and pharmacogenetics of mood disorders.

Serretti A.

Psychiatr Pol. 2017 Apr 30;51(2):197-203. doi: 10.12740/PP/68914. Epub 2017 Apr 30. Review. English, Polish.

6.

The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.

Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2017 Jul;27(7):625-632. doi: 10.1016/j.euroneuro.2017.05.004. Epub 2017 May 31.

PMID:
28579072
7.

Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.

Calabrò M, Porcelli S, Crisafulli C, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS, Albani D, Raimondi I, Forloni G, Bin S, Mattiaccio A, Mantovani V, Jun TY, Pae CU, Serretti A.

Adv Ther. 2017 Jun;34(6):1482-1497. doi: 10.1007/s12325-017-0555-2. Epub 2017 May 16.

PMID:
28508933
8.

Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1.

Calabrò M, Mandelli L, Crisafulli C, Sidoti A, Jun TY, Lee SJ, Han C, Patkar AA, Masand PS, Pae CU, Serretti A.

Neuropsychobiology. 2016;74(3):159-168. doi: 10.1159/000468543. Epub 2017 May 12.

PMID:
28494468
9.

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison.

Pae CU, Wang SM, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, Serretti A, Emsley R.

Int Clin Psychopharmacol. 2017 Sep;32(5):235-248. doi: 10.1097/YIC.0000000000000177.

PMID:
28430670
10.

Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression.

Culverhouse RC, Saccone NL, Horton AC, Ma Y, Anstey KJ, Banaschewski T, Burmeister M, Cohen-Woods S, Etain B, Fisher HL, Goldman N, Guillaume S, Horwood J, Juhasz G, Lester KJ, Mandelli L, Middeldorp CM, Olié E, Villafuerte S, Air TM, Araya R, Bowes L, Burns R, Byrne EM, Coffey C, Coventry WL, Gawronski KA, Glei D, Hatzimanolis A, Hottenga JJ, Jaussent I, Jawahar C, Jennen-Steinmetz C, Kramer JR, Lajnef M, Little K, Zu Schwabedissen HM, Nauck M, Nederhof E, Petschner P, Peyrot WJ, Schwahn C, Sinnamon G, Stacey D, Tian Y, Toben C, Van der Auwera S, Wainwright N, Wang JC, Willemsen G, Anderson IM, Arolt V, Åslund C, Bagdy G, Baune BT, Bellivier F, Boomsma DI, Courtet P, Dannlowski U, de Geus EJ, Deakin JF, Easteal S, Eley T, Fergusson DM, Goate AM, Gonda X, Grabe HJ, Holzman C, Johnson EO, Kennedy M, Laucht M, Martin NG, Munafò MR, Nilsson KW, Oldehinkel AJ, Olsson CA, Ormel J, Otte C, Patton GC, Penninx BW, Ritchie K, Sarchiapone M, Scheid JM, Serretti A, Smit JH, Stefanis NC, Surtees PG, Völzke H, Weinstein M, Whooley M, Nurnberger JI Jr, Breslau N, Bierut LJ.

Mol Psychiatry. 2017 Apr 4. doi: 10.1038/mp.2017.44. [Epub ahead of print]

PMID:
28373689
11.

Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls.

Balestri M, Crisafulli C, Donato L, Giegling I, Calati R, Antypa N, Schneider B, Marusic D, Tarozzi ME, Marusic D, Paragi M, Hartmann AM, Konte B, Marsano A, Serretti A, Rujescu D.

J Psychiatr Res. 2017 Aug;91:98-104. doi: 10.1016/j.jpsychires.2017.03.009. Epub 2017 Mar 10.

PMID:
28327445
12.

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.

Dold M, Bartova L, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

J Psychiatr Res. 2017 Aug;91:1-13. doi: 10.1016/j.jpsychires.2017.02.020. Epub 2017 Feb 27.

PMID:
28284107
13.

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.

Fabbri C, Crisafulli C, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.

Eur Arch Psychiatry Clin Neurosci. 2017 Mar 4. doi: 10.1007/s00406-017-0766-1. [Epub ahead of print]

PMID:
28260126
14.

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.

Kato M, Takekita Y, Koshikawa Y, Sakai S, Bandou H, Nishida K, Sunada N, Onohara A, Hatashita Y, Serretti A, Kinoshita T.

J Psychiatr Res. 2017 Jun;89:97-104. doi: 10.1016/j.jpsychires.2017.02.003. Epub 2017 Feb 3.

PMID:
28213170
15.

The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.

Mandelli L, Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU, Serretti A.

Adv Ther. 2017 Mar;34(3):713-724. doi: 10.1007/s12325-017-0482-2. Epub 2017 Jan 31.

PMID:
28144920
16.

Maoa and Maob polymorphisms and personality traits in suicide attempters and healthy controls: a preliminary study.

Balestri M, Calati R, Serretti A, Hartmann AM, Konte B, Friedl M, Giegling I, Rujescu D.

Psychiatry Res. 2017 Mar;249:212-217. doi: 10.1016/j.psychres.2017.01.020. Epub 2017 Jan 10.

PMID:
28119174
17.

Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics.

Giegling I, Hosak L, Mössner R, Serretti A, Bellivier F, Claes S, Collier DA, Corrales A, DeLisi LE, Gallo C, Gill M, Kennedy JL, Leboyer M, Maier W, Marquez M, Massat I, Mors O, Muglia P, Nöthen MM, Ospina-Duque J, Owen MJ, Propping P, Shi Y, St Clair D, Thibaut F, Cichon S, Mendlewicz J, O'Donovan MC, Rujescu D.

World J Biol Psychiatry. 2017 Oct;18(7):492-505. doi: 10.1080/15622975.2016.1268715. Epub 2017 Jan 23.

PMID:
28112043
18.

A New Prediction Model for Evaluating Treatment-Resistant Depression.

Kautzky A, Baldinger-Melich P, Kranz GS, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S.

J Clin Psychiatry. 2017 Feb;78(2):215-222. doi: 10.4088/JCP.15m10381.

PMID:
28068461
19.

Corrigendum to 'Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease' [J. Neurol. Sci. 370 (November 2016) 162-166].

Porcelli S, Crisafulli C, Donato L, Calabrò M, Politis A, Liappas I, Albani D, Atti AR, Salfi R, Raimondi I, Forloni G, Papadimitriou GN, De Ronchi D, Serretti A.

J Neurol Sci. 2017 Jan 15;372:49. doi: 10.1016/j.jns.2016.11.031. Epub 2016 Nov 19. No abstract available.

PMID:
28017245
20.

Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.

Fabbri C, Boriani G, Diemberger I, Filippi MG, Ravegnini G, Hrelia P, Minarini A, Albani D, Forloni G, Angelini S, Serretti A.

Basic Clin Pharmacol Toxicol. 2017 May;120(5):482-490. doi: 10.1111/bcpt.12720. Epub 2017 Jan 5.

PMID:
27893184

Supplemental Content

Loading ...
Support Center